Development and biomedical applications of highly sensitive enzyme activity assays of thioredoxin, thioredoxin reductase and glutaredoxin
Author: Montano, Sergio J
Date: 2013-06-14
Location: Samuelssonsalen, Scheeles väg 2, Karolinska institutet Solna.
Time: 10.00
Department: Inst för medicinsk biokemi och biofysik / Dept of Medical Biochemistry and Biophysics
Abstract
Oxidative stress is implicated in the pathogenesis of many human diseases, thus it is interesting to study the relationship between antioxidants, the development and progression of diseases. The thioredoxin and glutaredoxin systems are ubiquitous redox-active proteins known to be induced in chronic inflammatory related processes, such as cancer and diabetes, to protect against oxidative stress. The thioredoxin system is composed of thioredoxin (Trx), thioredoxin reductase (TrxR) and NADPH. The glutaredoxin system comprises glutathione reductase (GR), glutathione (GSSG/GSH), glutaredoxin (Grx) and NADPH. Trx is an important antioxidant and a redox regulator, crucial for the activation of transcription factors and modulation of intra- and extracellular signaling pathways. While, Grx is another crucial redox regulator with an important role in maintaining intracellular GSH-disulfide-dithiol exchange, apoptosis and cell differentiation. In fact, Trx, Grx and TrxR have been suggested biomarkers for disease monitoring. Thus, there is a current need for new techniques to detect and monitor Trx, Grx and TrxR activities in human patient samples; since the traditional methods showed several limitations related to background, specificity and sensitivity.
The aim of this thesis was to develop highly sensitive and reproducible assays to enable analysis of Trx, TrxR and Grx activities in clinical patient samples. Thus, we optimized the synthesis of two fluorescent substrates, dieosin-diglutathione (Di-E-GSSG) and fluorescein labelled insulin (FITC-insulin), which both gave higher fluorescence upon disulfide reduction. The latter, FITC-insulin, was used to develop highly sensitive microplate assays for Trx (≥ 0.4 picomoles) and TrxR (≥ 40 femtomole). Moreover, this method allowed reproducible measurements of re-activated Trx, commonly present in frozen or over-oxidized samples from cell, tissue (biopsies) and blood plasma origin (manuscript I). The former Di-E-GSSG, was an excellent substrate of Grx and could be used to glutathionylate proteins (such as BSA, yielding E-GS-BSA), thus becoming a useful fluorescent marker for glutathionylated proteins in gel electrophoresis. This mixed disulfide substrate, E-GS-BSA, allowed measurements of Grx1 and Grx2 activities in picomole concentrations (manuscript II). E-GS-BSA was further a key substrate for reverse-S-glutathionylation catalysis studies, which facilitated the characterization and study of the catalytic properties of human recombinant Grx5 (paper IV). In addition, we applied these optimized methods to the study of relevant clinical samples from patients showing a mutation in the selenocysteine insertion sequence–binding protein 2 gene, which lead to a multisystem selenoprotein deficiency disorder. Our measurements of TrxR activity in skin biopsies and PBMCs from these patients, showed significant decreased TrxR activity and concomitant increased of ROS levels when compared to healthy controls (paper III).
In conclusion, we present novel sensitive tools to study Trx, TrxR and Grx activities in complex samples from biological origin. Since these redox enzymes have been suggested as potential biomarkers for several diseases; the actual relevance of our newly developed methodologies, goes beyond the enzymatic measurements performed, as these methods might assist in detecting and/or analyzing disease progression with clear biomedical applications.
The aim of this thesis was to develop highly sensitive and reproducible assays to enable analysis of Trx, TrxR and Grx activities in clinical patient samples. Thus, we optimized the synthesis of two fluorescent substrates, dieosin-diglutathione (Di-E-GSSG) and fluorescein labelled insulin (FITC-insulin), which both gave higher fluorescence upon disulfide reduction. The latter, FITC-insulin, was used to develop highly sensitive microplate assays for Trx (≥ 0.4 picomoles) and TrxR (≥ 40 femtomole). Moreover, this method allowed reproducible measurements of re-activated Trx, commonly present in frozen or over-oxidized samples from cell, tissue (biopsies) and blood plasma origin (manuscript I). The former Di-E-GSSG, was an excellent substrate of Grx and could be used to glutathionylate proteins (such as BSA, yielding E-GS-BSA), thus becoming a useful fluorescent marker for glutathionylated proteins in gel electrophoresis. This mixed disulfide substrate, E-GS-BSA, allowed measurements of Grx1 and Grx2 activities in picomole concentrations (manuscript II). E-GS-BSA was further a key substrate for reverse-S-glutathionylation catalysis studies, which facilitated the characterization and study of the catalytic properties of human recombinant Grx5 (paper IV). In addition, we applied these optimized methods to the study of relevant clinical samples from patients showing a mutation in the selenocysteine insertion sequence–binding protein 2 gene, which lead to a multisystem selenoprotein deficiency disorder. Our measurements of TrxR activity in skin biopsies and PBMCs from these patients, showed significant decreased TrxR activity and concomitant increased of ROS levels when compared to healthy controls (paper III).
In conclusion, we present novel sensitive tools to study Trx, TrxR and Grx activities in complex samples from biological origin. Since these redox enzymes have been suggested as potential biomarkers for several diseases; the actual relevance of our newly developed methodologies, goes beyond the enzymatic measurements performed, as these methods might assist in detecting and/or analyzing disease progression with clear biomedical applications.
List of papers:
I. Montano SJ, Lu J, Gustafsson TN, Holmgren A. Sensitive activity assays of mammalian thioredoxin and thioredoxin reductase: Fluorescent disulfide substrates, mechanisms and use with tissue samples. [Manuscript]
II. Montano SJ, Coppo L, Padilla A, Holmgren A. Determination of glutaredoxin enzyme activity and S-glutathionylation using fluorescent glutathione. [Manuscript]
III. Schoenmakers E, Agostini M, Mitchell C, Schoenmakers N, Papp L, Rajanayagam O, Padidela R, Ceron-Gutierrez L, Doffinger R, Prevosto C, Luan J, Montano S, Lu J, Castanet M, Clemons N, Groeneveld M, Castets P, Karbaschi M, Aitken S, Dixon A, Williams J, Campi I, Blount M, Burton H, Muntoni F, O'Donovan D, Dean A, Warren A, Brierley C, Baguley D, Guicheney P, Fitzgerald R, Coles A, Gaston H, Todd P, Holmgren A, Khanna KK, Cooke M, Semple R, Halsall D, Wareham N, Schwabe J, Grasso L, Beck-Peccoz P, Ogunko A, Dattani M, Gurnell M, Chatterjee K. Mutations in the selenocysteine insertion sequence–binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans. The Journal of Clinical Investigation. 2010 Dec; 120(12): 4220-35.
Fulltext (DOI)
Pubmed
View record in Web of Science®
IV. Johansson C, Roos AK, Montano SJ, Sengupta R, Filippakopoulos P, Guo K, von Delft F, Holmgren A, Oppermann U, Kavanagh KL. The crystal structure of human GLRX5: iron−sulfur cluster co-ordination, tetrameric assembly and monomer activity. Biochemical Journal. 2011 Jan 15; 433(2): 303-11.
Fulltext (DOI)
Pubmed
View record in Web of Science®
I. Montano SJ, Lu J, Gustafsson TN, Holmgren A. Sensitive activity assays of mammalian thioredoxin and thioredoxin reductase: Fluorescent disulfide substrates, mechanisms and use with tissue samples. [Manuscript]
II. Montano SJ, Coppo L, Padilla A, Holmgren A. Determination of glutaredoxin enzyme activity and S-glutathionylation using fluorescent glutathione. [Manuscript]
III. Schoenmakers E, Agostini M, Mitchell C, Schoenmakers N, Papp L, Rajanayagam O, Padidela R, Ceron-Gutierrez L, Doffinger R, Prevosto C, Luan J, Montano S, Lu J, Castanet M, Clemons N, Groeneveld M, Castets P, Karbaschi M, Aitken S, Dixon A, Williams J, Campi I, Blount M, Burton H, Muntoni F, O'Donovan D, Dean A, Warren A, Brierley C, Baguley D, Guicheney P, Fitzgerald R, Coles A, Gaston H, Todd P, Holmgren A, Khanna KK, Cooke M, Semple R, Halsall D, Wareham N, Schwabe J, Grasso L, Beck-Peccoz P, Ogunko A, Dattani M, Gurnell M, Chatterjee K. Mutations in the selenocysteine insertion sequence–binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans. The Journal of Clinical Investigation. 2010 Dec; 120(12): 4220-35.
Fulltext (DOI)
Pubmed
View record in Web of Science®
IV. Johansson C, Roos AK, Montano SJ, Sengupta R, Filippakopoulos P, Guo K, von Delft F, Holmgren A, Oppermann U, Kavanagh KL. The crystal structure of human GLRX5: iron−sulfur cluster co-ordination, tetrameric assembly and monomer activity. Biochemical Journal. 2011 Jan 15; 433(2): 303-11.
Fulltext (DOI)
Pubmed
View record in Web of Science®
Institution: Karolinska Institutet
Supervisor: Holmgren, Arne
Issue date: 2013-05-23
Rights:
Publication year: 2013
ISBN: 978-91-7549-208-7
Statistics
Total Visits
Views | |
---|---|
Development ...(legacy) | 1094 |
Development ... | 239 |
Total Visits Per Month
March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | September 2024 | |
---|---|---|---|---|---|---|---|
Development ... | 3 | 0 | 1 | 3 | 4 | 6 | 2 |
File Visits
Views | |
---|---|
Thesis_Montano.pdf(legacy) | 576 |
Spikblad_Montano.pdf(legacy) | 288 |
Thesis_Montano.pdf | 266 |
Spikblad_Montano.pdf | 46 |
Avhandling Sergio Montano.pdf(legacy) | 2 |
Spikblad_Montano.pdf.txt(legacy) | 2 |
Thesis_Montano.pdf.txt(legacy) | 2 |
Top country views
Views | |
---|---|
United States | 483 |
Sweden | 104 |
Germany | 91 |
China | 90 |
South Korea | 44 |
Russia | 39 |
Spain | 35 |
France | 24 |
United Kingdom | 18 |
India | 13 |
Top cities views
Views | |
---|---|
Ashburn | 50 |
Stockholm | 42 |
Sunnyvale | 35 |
Kiez | 31 |
Beijing | 26 |
Romeo | 23 |
Moscow | 17 |
Seoul | 16 |
Almería | 8 |
Dublin | 7 |